RespireRx Pharmaceuticals Inc (RSPI)

[fly_fisherman]

I Agree ...

Already the case with how KRM-II drug helped the epilepsy patient.

In my opinion that was major huge. Definitely drew the attention of more eyes to the stock. It could very well have a delayed run because of that. However, there are those wanting their shares too. The recent small dilution is being gobbled up.

The powers that be that control this were not ready to move it. We will know when we have that 100+ million share day.

$RSPI has in place a truly undervalued patented/IP drug pipeline.

This will explode as either a delayed reaction to the sleep apnea and KRM-II drug or possibly when we get funding/partnership news.

Thats where Ponto Ventures comes in. They have been engaged since Mid December 2023.

Patience...